Atlanta Capital Management Co. L L C Purchases 399,301 Shares of Teleflex Incorporated (TFX)

Atlanta Capital Management Co. L L C raised its position in shares of Teleflex Incorporated (NYSE:TFX) by 17.7% in the third quarter, Holdings Channel reports. The fund owned 2,650,228 shares of the medical technology company’s stock after acquiring an additional 399,301 shares during the quarter. Teleflex makes up approximately 3.3% of Atlanta Capital Management Co. L L C’s portfolio, making the stock its biggest holding. Atlanta Capital Management Co. L L C owned about 0.06% of Teleflex worth $705,199,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the business. Raymond James Trust N.A. increased its holdings in shares of Teleflex by 12.7% in the third quarter. Raymond James Trust N.A. now owns 1,877 shares of the medical technology company’s stock valued at $500,000 after purchasing an additional 211 shares during the last quarter. DekaBank Deutsche Girozentrale increased its holdings in shares of Teleflex by 7.0% in the third quarter. DekaBank Deutsche Girozentrale now owns 3,235 shares of the medical technology company’s stock valued at $856,000 after purchasing an additional 213 shares during the last quarter. Metropolitan Life Insurance Co. NY increased its holdings in shares of Teleflex by 1.9% in the second quarter. Metropolitan Life Insurance Co. NY now owns 13,589 shares of the medical technology company’s stock valued at $3,645,000 after purchasing an additional 251 shares during the last quarter. Security Asset Management increased its holdings in shares of Teleflex by 4.2% in the second quarter. Security Asset Management now owns 6,935 shares of the medical technology company’s stock valued at $1,860,000 after purchasing an additional 282 shares during the last quarter. Finally, Parallel Advisors LLC increased its holdings in shares of Teleflex by 200.0% in the second quarter. Parallel Advisors LLC now owns 450 shares of the medical technology company’s stock valued at $120,000 after purchasing an additional 300 shares during the last quarter. 93.76% of the stock is owned by institutional investors and hedge funds.

Several research firms recently commented on TFX. Piper Jaffray Companies increased their price target on Teleflex to $310.00 and gave the company an “overweight” rating in a report on Friday, November 2nd. Needham & Company LLC reaffirmed a “buy” rating and issued a $315.00 price target on shares of Teleflex in a report on Friday, November 2nd. Barclays began coverage on Teleflex in a report on Monday, October 15th. They issued an “equal weight” rating and a $266.00 price target for the company. ValuEngine raised Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, September 13th. Finally, TheStreet cut Teleflex from a “b” rating to a “c+” rating in a report on Friday, August 3rd. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $289.38.

In related news, Director Benson Smith sold 9,331 shares of the stock in a transaction that occurred on Monday, September 17th. The stock was sold at an average price of $266.73, for a total value of $2,488,857.63. Following the completion of the transaction, the director now directly owns 77,887 shares in the company, valued at $20,774,799.51. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Thomas E. Powell sold 5,200 shares of the stock in a transaction that occurred on Friday, August 31st. The stock was sold at an average price of $247.55, for a total value of $1,287,260.00. Following the completion of the transaction, the chief financial officer now owns 10,723 shares of the company’s stock, valued at $2,654,478.65. The disclosure for this sale can be found here. Insiders sold 82,329 shares of company stock valued at $21,240,993 over the last quarter. 2.56% of the stock is currently owned by company insiders.

Shares of Teleflex stock opened at $252.66 on Monday. The company has a market capitalization of $11.62 billion, a P/E ratio of 30.08, a price-to-earnings-growth ratio of 2.04 and a beta of 1.12. Teleflex Incorporated has a fifty-two week low of $227.52 and a fifty-two week high of $288.78. The company has a quick ratio of 1.51, a current ratio of 2.26 and a debt-to-equity ratio of 0.83.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, November 1st. The medical technology company reported $2.52 earnings per share for the quarter, topping the consensus estimate of $2.41 by $0.11. The company had revenue of $609.70 million during the quarter, compared to analyst estimates of $609.05 million. Teleflex had a return on equity of 18.04% and a net margin of 2.81%. The firm’s revenue for the quarter was up 14.0% compared to the same quarter last year. During the same period in the prior year, the business posted $2.12 earnings per share. Equities research analysts predict that Teleflex Incorporated will post 9.91 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 14th. Investors of record on Thursday, November 15th will be given a $0.34 dividend. The ex-dividend date of this dividend is Wednesday, November 14th. This represents a $1.36 annualized dividend and a yield of 0.54%. Teleflex’s payout ratio is 16.19%.

ILLEGAL ACTIVITY NOTICE: This article was first reported by WKRB News and is the sole property of of WKRB News. If you are viewing this article on another website, it was stolen and reposted in violation of United States and international trademark and copyright laws. The correct version of this article can be accessed at https://www.wkrb13.com/2018/11/26/atlanta-capital-management-co-l-l-c-purchases-399301-shares-of-teleflex-incorporated-tfx.html.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease.

Recommended Story: How does inflation affect different investments?

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply